|
SPRED2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79648999999449E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.1375000004471E-07 |
| Normal-vs-Stage2 |
8.251900E-02 |
| Normal-vs-Stage3 |
5.509600E-02 |
| Normal-vs-Stage4 |
2.841100E-03 |
| Stage1-vs-Stage2 |
1.831220E-01 |
| Stage1-vs-Stage3 |
3.460400E-03 |
| Stage1-vs-Stage4 |
3.718800E-01 |
| Stage2-vs-Stage3 |
6.178200E-01 |
| Stage2-vs-Stage4 |
5.997600E-01 |
| Stage3-vs-Stage4 |
1.736580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.430680E-04 |
| Normal-vs-AfricanAmerican |
1.216430E-02 |
| Normal-vs-Asian |
9.98690000000302E-05 |
| Caucasian-vs-AfricanAmerican |
2.065400E-01 |
| Caucasian-vs-Asian |
3.690500E-02 |
| AfricanAmerican-vs-Asian |
8.661000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.382700E-03 |
| Normal-vs-Female |
1.51417999999515E-05 |
| Male-vs-Female |
3.090800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.43670000025176E-07 |
| Normal-vs-Age(41-60Yrs) |
4.248300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.152040E-01 |
| Normal-vs-Age(81-100Yrs) |
7.950200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.352000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.415600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.325560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.775700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.918800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.418000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.042300E-02 |
| Classical-VS-Follicular |
1.249930E-02 |
| Classical-VS-Other |
3.633000E-01 |
| Classical-VS-Normal |
2.27150000031706E-07 |
| Tall-VS-Follicular |
6.112400E-01 |
| Tall-VS-Other |
8.183400E-01 |
| Tall-VS-Normal |
3.422300E-02 |
| Follicular-VS-Other |
9.598000E-01 |
| Follicular-VS-Normal |
1.138970E-01 |
| Other-VS-Normal |
3.228200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.022800E-03 |
| Normal-vs-N1 |
3.983900E-03 |
| N0-vs-N1 |
4.678400E-01 |
|
|
